Most women at age 40 have roughly 3% of the egg supply they were born with, which translates to somewhere in the range of a few thousand to perhaps 20,000 or so remaining follicles, depending on where they started. That number surprises people who remember hearing “you’re born with all your eggs,” because the implication is that millions should still be available. In reality, egg loss begins before birth and accelerates sharply through the late thirties and forties, making the reserves at 40 far smaller than many expect.
What the Estimates Actually Look Like
A widely cited population model published in 2010 estimated that for 95% of women, only about 12% of their maximum pre-birth egg supply remains by age 30, and only about 3% by age 40.1PLoS ONE. Human Ovarian Reserve from Conception to the Menopause In absolute terms, the starting point matters enormously. A fetus at around 20 weeks of gestation may carry 6 to 7 million immature egg cells. By birth, that number has already dropped to roughly 1 to 2 million. By puberty, about 300,000 to 400,000 remain. By the late thirties, the count falls to approximately 25,000, and the pace of loss continues to steepen into the forties.2PubMed. Effect of surgery on ovarian reserve in women with endometriomas, endometriosis and controls So at 40, while the exact count varies widely from person to person, most women are working with a reservoir measured in the low thousands rather than the hundreds of thousands they had at puberty.
These figures describe primordial follicles, the tiny dormant structures in the ovary that each house an immature egg. Only a fraction of those follicles will ever wake up and develop into a mature, ovulatable egg. Over an entire reproductive lifetime, roughly 400 to 500 eggs are actually released through ovulation. The rest are lost to natural attrition along the way.
Why the Ovary Eliminates Most of Its Own Eggs
The sheer scale of egg loss can seem wasteful, but it is the normal biological process. More than 99% of follicles are eliminated rather than ovulated, primarily through a form of programmed cell death in the support cells surrounding each egg.3PubMed. Life and death of female gametes during oogenesis and folliculogenesis Every menstrual cycle, a batch of dormant follicles is recruited to start growing. Typically only one follicle “wins” and goes on to release a mature egg. The rest in that batch die off. This process, called follicular atresia, happens cycle after cycle, decade after decade, steadily whittling down the pool.
Recent research has begun to clarify that follicular atresia involves multiple cell-death pathways, not just the single mechanism scientists once assumed.4PubMed Central. Mechanisms of follicular atresia: focus on apoptosis, autophagy, and ferroptosis The practical takeaway for someone at 40 is that no lifestyle change or supplement can halt this process entirely. Egg loss is baked into ovarian biology from the very beginning. It accelerates noticeably after the mid-thirties and continues until menopause, when the functional reserve is essentially depleted.
Egg Quality Declines Alongside Quantity
The number of eggs remaining is only half the story. As women age, the eggs that remain are more likely to have chromosomal problems when they mature. This is the main reason miscarriage rates climb and fertility drops in the late thirties and forties, even among women who still have a reasonable number of eggs left. The underlying issue is that the cellular machinery inside the egg becomes less reliable over time, leading to errors when chromosomes are divided during maturation.
Specifically, mitochondria inside older eggs tend to function less efficiently, and the structural apparatus that separates chromosomes during cell division becomes more prone to mistakes.5PubMed. Alterations in oocyte mitochondrial number and function are related to spindle defects and occur with maternal aging in mice and humans Oxidative stress and mitochondrial damage both contribute to the rising rate of chromosomally abnormal eggs with age.6PubMed Central. Oocyte quality and aging
Data from IVF clinics, where embryos can be genetically tested before transfer, give a concrete sense of the quality shift. Among women aged 38 to 40, roughly 63% of embryos tested were chromosomally abnormal, compared to about 46% in women under 35.7Fertility and Sterility. Rate of aneuploidy and euploidy in PGT-A tested embryos and the chance of having at least one normal PGT-A embryo available per IVF cycle This means that even when a 40-year-old produces several eggs in an IVF cycle, the odds that any individual egg will result in a healthy embryo are lower. Many people focus on egg count and assume that having “enough” eggs is sufficient, but at 40, quality is the bigger bottleneck for most.
How to Measure Your Own Reserve
If you are wondering where you stand personally, two tests are commonly used to estimate ovarian reserve. The first is a blood test measuring anti-Müllerian hormone (AMH), a protein produced by small growing follicles in the ovary. Higher AMH generally indicates a larger remaining pool. The second is an antral follicle count (AFC), done via transvaginal ultrasound, which tallies the small follicles visible in the ovaries at the start of a cycle. AFC declines in a roughly linear fashion with age, dropping by a median of about 0.4 follicles per year.8PubMed. Age-specific nomogram for the decline in antral follicle count throughout the reproductive period
Both tests are useful for predicting how your ovaries would respond to stimulation medications in IVF, and fertility clinics rely on them heavily for treatment planning. But there is a common and important misconception worth flagging: a normal AMH result does not guarantee that getting pregnant will be easy, and a low AMH does not mean you cannot conceive naturally.
What AMH Does Not Tell You
AMH is a good marker of egg quantity. It is a much weaker predictor of your ability to conceive on your own in any given month. A large study of over 3,000 women trying to conceive found that those with low AMH (under 1 ng/mL) did have a somewhat reduced chance of conception compared to women with normal levels, but the difference was modest, not dramatic.9Fertility and Sterility. Antimüllerian hormone levels are associated with time to pregnancy in a cohort study of 3,150 women Another study found that natural conceptions occurred even at very low AMH concentrations, and that there was a large spread in how long it took women with similar AMH levels to conceive.10PubMed. Investigation of anti-Müllerian hormone concentrations in relation to natural conception rate and time to pregnancy
A study of women aged 30 to 42 did find that those with very low AMH (0.7 ng/mL or below) had significantly reduced per-cycle chances of conceiving, even after accounting for age.11PubMed Central. Antimüllerian Hormone as a Predictor of Natural Fecundability in Women Aged 30–42 Years So extremely low levels do seem to matter for natural fertility, but routine AMH testing in women who are not trying to conceive can generate unnecessary alarm. Age remains a stronger predictor of fertility than AMH alone, because age captures the quality decline that AMH does not measure.
One area where AMH does have clear predictive value is in estimating the timeline to menopause. Women with very low AMH in their late thirties or early forties tend to reach menopause sooner. Research found that women aged 35 to 39 with AMH below 0.20 ng/mL had a median time to menopause of about 10 years, while women aged 45 to 48 with the same low levels reached menopause in about 6 years.12PubMed Central. Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women AMH levels generally drop to very low readings about five years before the final menstrual period.13Human Reproduction Update. Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic review
Factors That Speed Up Egg Loss
While the broad trajectory of egg depletion is biologically set, certain exposures can accelerate it. Smoking is the best-studied culprit. Research consistently shows that women who smoke experience diminished ovarian reserve earlier than nonsmokers, and that constituents of tobacco smoke, including carbon monoxide, nicotine, cadmium, and certain hydrocarbons, can damage follicles directly, impair egg development, and trigger premature death of dormant eggs.14PubMed Central. Association between cigarette smoking and ovarian reserve among women seeking fertility care One older but influential study concluded that women who smoke develop clinically detectable diminished ovarian reserve faster than nonsmokers, and that this accelerated reserve loss may be the primary reason smoking reduces fertility.15PubMed. Cigarette smoking accelerates the development of diminished ovarian reserve as evidenced by the clomiphene citrate challenge test
Ovarian surgery is another known threat to the egg reserve. Women who undergo surgery for ovarian cysts called endometriomas (chocolate cysts associated with endometriosis) can see a significant drop in their AMH levels. In one study, patients who had endometrioma surgery experienced a roughly 48% decline in AMH at one month after the procedure, and levels remained depressed six months later.2PubMed. Effect of surgery on ovarian reserve in women with endometriomas, endometriosis and controls This does not mean the surgery was wrong, since endometriomas themselves can also harm the ovary, but it is a real trade-off that reproductive specialists weigh carefully.
Genetics also play a role. There is wide natural variation in how many eggs a woman starts with and how quickly she loses them, and some of that variation has a heritable component. Research has identified genetic variants associated with hormonal markers of ovarian reserve, and these variants differ across populations.16Human Reproduction. Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women A family history of early menopause can be a clue that your own reserve may decline faster than average, though it is far from a guarantee.
IVF Outcomes at 40 and Beyond
For women who turn to IVF at 40, the numbers are sobering but worth understanding clearly. A study tracking IVF outcomes in women aged 40 and older found an overall live birth rate of about 7% per embryo transfer, with a spontaneous miscarriage rate of 43%.17PubMed Central. Predictors of live birth and pregnancy success after in vitro fertilization in infertile women aged 40 and over The live birth rate dropped with each year of age: roughly 13% at age 40, declining to under 1% at 45 and beyond. These are per-transfer rates, so cumulative success across multiple cycles is somewhat higher, but the steep age gradient is unmistakable.
This is where the distinction between egg count and egg quality becomes clinically decisive. IVF can retrieve multiple eggs in a cycle, partially compensating for a lower reserve, but it cannot correct the chromosomal errors that become more common in older eggs. That is why success rates fall so sharply even when stimulation protocols are optimized.
For women in their forties who use donor eggs from younger women, the picture changes dramatically. Research comparing autologous (own egg) and donor egg IVF in women over 40 found cumulative live birth rates of roughly 29% to 43% with donor eggs, versus 1% to 13% with their own eggs, depending on exact age.18PubMed. Having a baby in your 40s with assisted reproductive technology: The reproductive dilemma of autologous versus donor oocytes The gap underscores that the uterus at 40 is generally capable of carrying a pregnancy, and that egg quality, not uterine aging, is the primary barrier.
Can Anything Improve Egg Quality at 40?
There is no proven way to increase your egg count once follicles are gone. However, there is growing interest in whether the quality of remaining eggs can be supported, particularly through mitochondrial health. Coenzyme Q10 (CoQ10), a naturally occurring compound involved in cellular energy production, has received the most research attention. Animal studies have shown that CoQ10 supplementation can restore mitochondrial function in aging eggs and improve fertility outcomes in older mice.19PubMed Central. Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging
Human data is less robust but encouraging. A review of clinical studies found evidence that CoQ10 supplementation can improve ovarian function, increase the number of retrieved eggs in IVF, and improve embryo quality, particularly in women with diminished ovarian reserve or advanced age.20PubMed Central. Exploring the protective effects of coenzyme Q10 on female fertility Many reproductive endocrinologists now suggest CoQ10 supplementation (often 400 to 600 mg daily) as a low-risk addition to IVF preparation, though it is not yet standard of care and should not be viewed as a substitute for timely intervention. The honest assessment is that no supplement can turn back the clock on a decade of egg aging, but modest improvements in mitochondrial function could matter at the margins.
Other supplements frequently discussed in fertility forums, including DHEA and vitamin D, have mixed evidence and are beyond the scope of what the current research strongly supports. If you are considering supplements before an IVF cycle, discuss specific options with a reproductive specialist who can tailor recommendations to your test results.
Egg Freezing and the Question of Timing
One of the most common practical questions for women around 40 is whether it is “too late” to freeze eggs. The short answer is that it is not impossible, but the math works much better at younger ages. Egg freezing captures eggs at their current quality. Eggs frozen at 33 will behave like 33-year-old eggs when thawed a decade later. Eggs frozen at 40 will still carry the higher chromosomal error rates of a 40-year-old’s eggs.
This means that a woman freezing eggs at 40 needs more of them to achieve the same probability of a future live birth as a woman who froze at 35, because a larger fraction of those eggs will turn out to be chromosomally abnormal. Most fertility specialists suggest that freezing at least 15 to 20 mature eggs gives a reasonable cumulative chance of a live birth for women in their early to mid-thirties, but a 40-year-old might need significantly more than that to reach the same odds, and producing that many eggs in one or two retrieval cycles becomes less likely as the reserve shrinks.
None of this means freezing at 40 is pointless. For someone who is certain they want to try with their own eggs later, any frozen eggs represent a form of insurance. But the expected return is lower, the cost per usable egg is higher, and the emotional investment is real. Women who freeze eggs at 40 should go in with realistic expectations, ideally after seeing their AMH and AFC results so they can estimate how many retrieval cycles might be needed.
Why the Range of “Normal” Is So Wide
One of the most frustrating aspects of ovarian reserve is how much it varies between individuals of the same age. Two 40-year-old women can have AMH levels that differ by a factor of ten. Some of that variation traces to genetics. Some traces to medical history, such as previous ovarian surgeries or chemotherapy. Some traces to environmental exposures like smoking. And some is simply random biological variation that researchers do not fully understand yet.
This wide spread means that population averages, while useful for framing the general picture, do not substitute for individual testing. A 40-year-old with high AMH and a strong AFC may have a meaningfully different fertility outlook than a 40-year-old with very low reserve markers. Both of them are “normal” for their age in the sense that both fall somewhere on the expected distribution, but their practical paths forward may look quite different. The woman with higher reserve might have a reasonable shot with IVF using her own eggs across several cycles; the woman with very low reserve might find that donor eggs offer a dramatically better chance of success.
For anyone at 40 wondering where they personally stand, the most useful first step is not reading population statistics but getting an AMH blood draw and an AFC ultrasound. Those two numbers, interpreted by a reproductive endocrinologist in the context of your specific goals, will tell you far more than any average can.